Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
SETD2 mutation + RUNX1 mutation
i
Other names:
RUNX1, RUNX Family Transcription Factor 1, Runt-Related Transcription Factor 1, Polyomavirus Enhancer-Binding Protein 2 Alpha B Subunit, SL3/AKV Core-Binding Factor Alpha B Subunit, SL3-3 Enhancer Factor 1 Alpha B Subunit, Runt Related Transcription Factor 1, Acute Myeloid Leukemia 1 Protein, Oncogene AML-1, PEBP2-Alpha B, PEA2-Alpha B, AMLCR1, CBFA2, AML1, Core-Binding Factor Subunit Alpha-2, AML1-EVI-1 Fusion Protein, Acute Myeloid Leukemia 1, Aml1 Oncogene, CBF-Alpha-2, AML1-EVI-1, PEBP2alpha
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
861
;
29072
Related biomarkers:
Expression
Mutation
CNA
Fusion
Others
‹
Chr t(8;21)(q22;q22) + RUNX1-RUNX1T1 fusion + KIT exon 17 mutation + CSF3R mutation (4)
Chr t(8;21)(q22;q22) + RUNX1-RUNX1T1 fusion + KIT exon 17 mutation (3)
RUNX1-RUNX1T1 fusion + KIT D816 (1)
SETD2 mutation + MGMT promoter methylation (1)
Chr t(8;21)(q22;q22) + RUNX1-RUNX1T1 fusion + KIT exon 17 mutation + CSF3R mutation (4)
Chr t(8;21)(q22;q22) + RUNX1-RUNX1T1 fusion + KIT exon 17 mutation (3)
RUNX1-RUNX1T1 fusion + KIT D816 (1)
SETD2 mutation + MGMT promoter methylation (1)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
SETD2 mutation + RUNX1 mutation
Acute Myelogenous Leukemia
SETD2 mutation + RUNX1 mutation
Acute Myelogenous Leukemia
ziftomenib
Sensitive: C3 – Early Trials
ziftomenib
Sensitive
:
C3
ziftomenib
Sensitive: C3 – Early Trials
ziftomenib
Sensitive
:
C3
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.